Krueger, S. K., Henderson, M. C., Siddens, L. K., VanDyke, J. E., Benninghoff, A. D., Karplus, P. A., . . . Williams, D. E. (2009). Characterization of Sulfoxygenation and Structural Implications of Human Flavin-Containing Monooxygenase Isoform 2 (FMO2.1) Variants S195L and N413K. American Society for Pharmacology and Experimental Therapeutics.
Chicago Style CitationKrueger, Sharon K., Marilyn C. Henderson, Lisbeth K. Siddens, Jonathan E. VanDyke, Abby D. Benninghoff, P. Andrew Karplus, Bjarte Furnes, Daniel Schlenk, i David E. Williams. Characterization of Sulfoxygenation and Structural Implications of Human Flavin-Containing Monooxygenase Isoform 2 (FMO2.1) Variants S195L And N413K. American Society for Pharmacology and Experimental Therapeutics, 2009.
Cita MLAKrueger, Sharon K., et al. Characterization of Sulfoxygenation and Structural Implications of Human Flavin-Containing Monooxygenase Isoform 2 (FMO2.1) Variants S195L And N413K. American Society for Pharmacology and Experimental Therapeutics, 2009.